Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin.
Publication
, Journal Article
Lenzi, R; Raber, MN; Frost, P; Schmidt, S; Abbruzzese, JL
Published in: Eur J Cancer
1993
Duke Scholars
Published In
Eur J Cancer
DOI
ISSN
0959-8049
Publication Date
1993
Volume
29A
Issue
11
Start / End Page
1634
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms, Unknown Primary
- Middle Aged
- Male
- Leucovorin
- Humans
- Fluorouracil
- Female
- Cisplatin
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Lenzi, R., Raber, M. N., Frost, P., Schmidt, S., & Abbruzzese, J. L. (1993). Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin. Eur J Cancer, 29A(11), 1634. https://doi.org/10.1016/0959-8049(93)90312-4
Lenzi, R., M. N. Raber, P. Frost, S. Schmidt, and J. L. Abbruzzese. “Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin.” Eur J Cancer 29A, no. 11 (1993): 1634. https://doi.org/10.1016/0959-8049(93)90312-4.
Lenzi R, Raber MN, Frost P, Schmidt S, Abbruzzese JL. Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin. Eur J Cancer. 1993;29A(11):1634.
Lenzi, R., et al. “Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin.” Eur J Cancer, vol. 29A, no. 11, 1993, p. 1634. Pubmed, doi:10.1016/0959-8049(93)90312-4.
Lenzi R, Raber MN, Frost P, Schmidt S, Abbruzzese JL. Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin. Eur J Cancer. 1993;29A(11):1634.
Published In
Eur J Cancer
DOI
ISSN
0959-8049
Publication Date
1993
Volume
29A
Issue
11
Start / End Page
1634
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms, Unknown Primary
- Middle Aged
- Male
- Leucovorin
- Humans
- Fluorouracil
- Female
- Cisplatin
- Antineoplastic Combined Chemotherapy Protocols